Clinical Trial Update: Effect of Irvingia Gabonensis Administration on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity [NA]

View source ↗

Summary

A completed clinical trial evaluating the effects of Irvingia gabonensis on metabolic syndrome, insulin secretion, and insulin sensitivity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Irvingia Gabonensis (Irvingia gabonensis extract)

Snippet

Sponsor: University of Guadalajara | Conditions: Metabolic Syndrome X | NA | Status: COMPLETED | Results posted: 2020-10-08